Literature DB >> 8526614

Superoxide radical and xanthine oxidoreductase activity in the human heart during cardiac operations.

S W MacGowan1, M C Regan, C Malone, O Sharkey, L Young, T F Gorey, A E Wood.   

Abstract

BACKGROUND: The results of clinical trials of xanthine oxidoreductase inhibition in cardiac surgery are encouraging, although studies have failed to localize the enzyme to the human heart and to localize free radical activity to fresh human heart.
METHODS: We adapted a histochemical staining technique based on the reduction of nitro blue tetrazolium to formazan by superoxide radical. In six samples of right atrium graded blindly on a scale of 0 through 4, strong staining (median grade, 3) of the microvasculature was seen. This was blocked by allopurinol in paired sections (median grade, 1; p < 0.01). Chemiluminescence can be used as an index of superoxide radical activity. Atrial samples were taken from 13 patients at five time points during coronary bypass grafting and placed in buffered luminol. Then chemiluminescence was measured.
RESULTS: A 15-fold rise in chemiluminescence (295.93 +/- 39.47 mV) was demonstrated during reperfusion compared with the control value (19.06 +/- 0.47 mV). Chemiluminescence at 1 minute after release of the cross-clamp was significantly higher (p < 0.05) by analysis of variance versus values obtained before bypass and 1 minute before and 30 minutes after reperfusion.
CONCLUSIONS: In this study we have identified superoxide radical activity and a possible generating system (xanthine oxidoreductase) in the human heart.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526614     DOI: 10.1016/0003-4975(95)00616-S

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

2.  Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.

Authors:  K Ichida; Y Amaya; N Kamatani; T Nishino; T Hosoya; O Sakai
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

Review 3.  Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

Authors:  Zoltan Ungvári; Sachin A Gupte; Fabio A Recchia; Sándor Bátkai; Pál Pacher
Journal:  Curr Vasc Pharmacol       Date:  2005-07       Impact factor: 2.719

4.  Xanthine oxidase and uric Acid in atrial fibrillation.

Authors:  Panagiotis Korantzopoulos; Konstantinos P Letsas; Tong Liu
Journal:  Front Physiol       Date:  2012-05-24       Impact factor: 4.566

Review 5.  The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation.

Authors:  Yawen Deng; Fei Liu; Xiaolei Yang; Yunlong Xia
Journal:  Front Cardiovasc Med       Date:  2021-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.